About Us
Executive Management
Board of Directors
Corporate Governance
Contact Us
Clinical Trials
Clinical Trials Overview
Ibrutinib (PCI-32765),
BTK-inhibitor
PCI-27483,
Factor VIIa-inhibitor
Abexinostat HCl (PCI-24781),
PanHDAC-inhibitor
Glossary of Terms
Pipeline
Bruton's Tyrosine Kinase (BTK) Inhibitor Program
Histone Deacetylase Inhibitor Program
Factor VIIa Inhibitor
Motexafin Gadolinium
Glossary of Terms
Investors & Media
Stock Information
Events & Webcasts
SEC Filings
Corporate Governance
Press Releases
Annual Reports & Meetings
Presentations & Articles
Request Printed Materials
Investor FAQs
Glossary of Terms
IR Contact
Careers
Contact Us
Contact Info & Map
IR Contact
Home
About Pharmacyclics
Corporate Governance
Print
Email
Corporate Governance
Executive Management
Board of Directors
Corporate Governance
Code of Business Conduct and Ethics
Audit Committee Charter
Compensation Committee Charter
Nominating & Corporate Governance Committee
Contact Us
Corporate Governance
Code of Business Conduct and Ethics
Board Committee Charters
Audit Committee Charter
Nominating & Corporate Governance Committee
Compensation Committee Charter
